JPRN-UMIN000004904已完成1 期
HLA haploidentical stem cell transplantation using myeloablative regimen including ATG - haplo-full with ATG
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 45years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Allergy for the agents used in conditioning or GVHD prophylaxis 2) Patients who are considered as inappropriate with other reasons
研究者
相似试验
招募中
2 期
HLA-haploidentical stem cell transplantation using a low dose ATG and steroidJPRN-UMIN000028845Hyogo College of Medicine100
已完成
不适用
HLA-haploidentical allogeneic stem cell transplantation for refractory hematopoietic diseasesAcute myeloid leukemia(AML) Acute lymphoblastic leukemia (ALL) Secondary acute myelogenous leukemia Chronic myeloid leukemia (CML) Myelodysplastic syndrome (MDS)JPRN-UMIN000002069Hematology, Osaka City University, Graduate School of Medicine17
已完成
2 期
HLA-haploidentical allogeneic stem cell transplantation for refractory hematopoietic malignancies (OCU13-3)Acute myeloid leukemia(AML) Acute lymphoblastic leukemia (ALL) Chronic myeloid leukemia (CML) Myelodysplastic syndrome (MDS)JPRN-UMIN000011293Osaka City University35
已完成
2 期
HLA-haploidentical allogeneic stem cell transplantation for Adult T-cell leukemia/lymphoma (ATL/L) and refractory aggressive lymphomaAdult T-cell leukemia/lymphoma (acute type and lymphoma type) Malignant lymphoma (aggressive hodgkin and non-hodgkin lymphoma)JPRN-UMIN000002606Hematology, Osaka City University, Graduate School of Medicine17
招募中
2 期
HLA haploidentical hematopoietic stem cell transplantation, Phase II trialhematologic malignancies, bone marrow failure syndrome, and other hematological disorders which requires hematopoietic stem cell transplantationJPRN-UMIN000027049Hyogo College of Medicine100